Name (Synonyms) | Correlation | |
---|---|---|
drug1188 | Two doses of low dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 Wiki | 1.00 |
drug1187 | Two doses of high dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 Wiki | 1.00 |
drug1194 | Two doses of placebo at the schedule of day 0,28 Wiki | 1.00 |
drug1191 | Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 Wiki | 1.00 |
Name (Synonyms) | Correlation |
---|
There is one clinical trial.
We are aiming to see if participant deterioration due to suspected coronavirus in a designated location (e.g. hotel) can be identified sooner by wearing the sensor. If we can identify sick participants early, participants are more likely to have better outcomes; we believe that the sensor can help us do this. The sensor measures heart rate, respiratory rate and temperature every 2 minutes and this can be reviewed by the clinical team looking after the participants.
Description: Detection of clinical deterioration using wearable sensors resulting in healthcare review (e.g. GP telephone consultation)
Measure: Deterioration resulting in healthcare review Time: 1 yearDescription: Deterioration resulting in hospitalisation
Measure: Hospitalisation Time: 1 yearDescription: GAD-7 questionnaire (repsonses noted on Likert scales)
Measure: Participant anxiety Time: 1 yearDescription: PHQ-9 questionnaire (responses noted on Likert scales)
Measure: Participant depression Time: 1 year